CWWeekly April 28th 2008 Issue

Friday, May 2, 2008 03:44 PM

Top News

 

PeerView Acquires Veritas’ Clinical Trial Disclosure Business

Newtown, Pa.-based PeerView, a provider of medical journal publishing technology, acquired the clinical results disclosure platform from Cambridge, Mass.-based Veritas Medicine. The platform, called Veritas Clinical Trial Register (VCTR—or ‘victor’) was one of the last remaining pieces of Veritas’ business offerings after it discontinued its patient recruitment services and laid off a number of employees in February 2008.

Novotech Expanding in Asia-Pac, U.S.

Having opened offices in both Hydera-bad, India, and Seoul, Korea, recently, Novotech shared its plans for an ambitious expansion throughout the Asia-Pacific region. The Korean office has three employees, and India has a slightly different model with a manager and 26 monitors that Novotech has arranged to have through a partner and is therefore able to cover the entire country. Novotech’s plans do not stop with Asia-Pac. The company is also looking at opportunities for creating a bigger presence in North America to get closer to its clients there.

Other breaking news...      

Company Profile: An interview with Dan Ulrey, president and chief executive officer, Midwest Clinical Support, Inc.

To read the full articles for this issue or for more information on these and other breaking stories, please click here for subscription information.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs